Oral News and Research

RSS

Study shows both IDH-mutant WHO-defined molecular subgroups could benefit from PCV chemoradiotherapy

A recent, updated predictive analysis of the three WHO-defined molecular subgroups based on isocitrate dehydrogenase 1/2 (IDH) mutation status and 1p/19q co-deletion status represented in the high-risk treatment arms of the NRG Oncology clinical trial NRG-RTOG 9802 indicates that both IDH-mutant sub-groups (IDHmut-noncodel and IDHmut-codel) could benefit from the addition of PCV chemotherapy to radiotherapy treatment.

3 Jun 2019

Combination immunotherapy shows promise in pre-surgical setting for early-stage lung cancers

Neoadjuvant, or pre-surgical, treatment with nivolumab plus ipilimumab resulted in an overall major pathologic response rate of 33 percent of treated patients with early-stage, resectable non-small cell lung cancers, meaning these patients had less than or equal to 10 percent viable tumor remaining at surgery.

3 Jun 2019

Oral androgen receptor inhibitor improves outcomes for men with mHSPC

Enzalutamide, an oral androgen receptor inhibitor, can improve outcomes for men with metastatic hormone-sensitive prostate cancer, according to a large study presented by Christopher Sweeney, MBBS of Dana-Farber Cancer Institute's Lank Center for Genitourinary Oncology, during the American Society of Clinical Oncology Annual Meeting.

3 Jun 2019

Cancer mortality at an all time low finds report

In a new Annual Report to the Nation on the Status of Cancer, researchers have found that death rates due to cancer have declined over among all age groups and both sexes in the United States between 1999 and 2016.

30 May 2019

Research provides new options for treatment of multi-drug resistant infections

A new study, published in 'Antimicrobial Agents and Chemotherapy' conducted by a University of Liverpool led research consortium, has helped develop a new treatment option for some multi-drug resistant infections.

30 May 2019

New case study provides definitive road map to bridge the gap between medicine and public health

Academic medical centers across the country and around the world are rapidly creating and expanding population health departments to bridge the worlds of clinical practice and public health. However, few frameworks exist to guide these efforts.

30 May 2019

Starving the fungus could help fight drug-resistant fungal infections

How do you fight a fungal infection that is becoming increasingly resistant to medicine? By starving it, found a team of University at Buffalo and Temple University researchers.

26 May 2019

Findings provide new insights about how intestine maximizes nutrient uptake

As food enters the intestine, it embarks on windy, lengthy journey. For most of the route, its surroundings don't appear to change much.

25 May 2019

US dentists write more opioid prescriptions than England dentists

Researchers from the University of Illinois at Chicago have found that dentists practicing in the U.S. write 37 times more opioid prescriptions than dentists practicing in England.

25 May 2019

Study proves cerebral emboli of stroke patients contain DNA from oral pathogens

Researchers at Tampere University have shown for the first time that the cerebral emboli of stroke patients contain DNA from oral pathogens.

24 May 2019

New pain management program sends 92% cancer surgery patients home with no opioids

A specialized pain management program for patients who underwent robotic surgery for urologic cancers resulted in just eight percent going home with narcotics after discharge, compared to 100 percent who would have received them without this enhanced recovery protocol.

23 May 2019

Research uncovers potential breakthrough in the understanding of tumor dormancy

Scientists at VCU Massey Cancer Center may have uncovered a primary method through which cancer cells exist undetected in an organism and received more than $1 million to investigate the potential for novel therapeutics that target and destroy cells in a specific state of tumor dormancy.

22 May 2019

Cannabidiol reduces cue-induced craving and anxiety in individuals with history of heroin abuse

Cannabidiol reduced cue-induced craving and anxiety in individuals with a history of heroin abuse, suggesting a potential role for it in helping to break the cycle of addiction, according to research conducted at the Icahn School of Medicine at Mount Sinai and published May 21 in the American Journal of Psychiatry.

21 May 2019

Virtual clinical trial: Improving methadone dosage for drug users with TB to prevent withdrawal symptoms

Drug users on methadone programs who contract tuberculosis should receive effective treatment while maintaining the correct level of methadone in their bodies, following a virtual clinical trial by pharmacy researchers at Aston University in partnership with drugs charity Addaction.

21 May 2019

Oral News and Research

Study shows both IDH-mutant WHO-defined molecular subgroups could benefit from PCV chemoradiotherapy

Combination immunotherapy shows promise in pre-surgical setting for early-stage lung cancers

Oral androgen receptor inhibitor improves outcomes for men with mHSPC

Cancer mortality at an all time low finds report

Research provides new options for treatment of multi-drug resistant infections

New case study provides definitive road map to bridge the gap between medicine and public health

Starving the fungus could help fight drug-resistant fungal infections

Findings provide new insights about how intestine maximizes nutrient uptake

US dentists write more opioid prescriptions than England dentists

Study proves cerebral emboli of stroke patients contain DNA from oral pathogens

New pain management program sends 92% cancer surgery patients home with no opioids

Research uncovers potential breakthrough in the understanding of tumor dormancy

Cannabidiol reduces cue-induced craving and anxiety in individuals with history of heroin abuse

Virtual clinical trial: Improving methadone dosage for drug users with TB to prevent withdrawal symptoms

New drug could alleviate symptoms of rare musculoskeletal condition

New app helps improve the lives of children with asthma

Study aims to optimize device implantation in patients with atrial fibrillation and stroke risk

LC-MS/MS test for progesterone outperforms traditional immunoassays

Charcoal-based toothpaste comes with 'real risks'

Statins' potential to treat MS unrelated to the drug's cholesterol lowering effects

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News